Fluxus lateralis chromatographicus immunoassay
Fundatur principium competitive ligaturae
Anticorpus cum pharmacopola dapibus conjugatis agit
AMRDT111 multae celeri test ornamentum pro sale
PRINCIPIUM.
Celeri Testi ornamentum AMRDT111 multiplex est immunoassay innixa principio vinciendi competitive.Medicamenta, quae in specimine urinae adesse possunt, contendunt contra suum proprium medicamentum conjugatum pro locis ligandis in proprio anticorpore.
Celeri test ornamentum AMRDT111 multiplex est fluxus chromatographicus lateralis immunoassay pro qualitate detectionis plurium medicamentorum et metabolitarum medicamentorum in urinis ad concentrationes sequentes abscissorum:
| Test | Calibrator | Abscise (ng/mL) |
| Amphetamine (AMP1000) | D-Amphetamine | 1,000 |
| Amphetamine (AMP500) | D-Amphetamine | 500 |
| Amphetamine (AMP300) | D-Amphetamine | 300 |
| Benzodiazepines (BZO300) | Oxazepam | 300 |
| Benzodiazepines (BZO200) | Oxazepam | 200 |
| Barbiturates (BAR) | Secobarbital | 300 |
| Buprenorphine (BUP) | Buprenorphine | 10 |
| COCAINUM (COC) | Benzoylecgnine | 300 |
| Cotinine (COT) | Cotinine | 200 |
| Methadone metabolite (EDDP) | 2-Ethylidine-1,5-dimethyl-3,3-diphenylpyrrolidine | 100 |
| Fentanyl (FYL) | Fentanyl | 200 |
| Ketamine (KET) | Ketamine | 1,000 |
| Synthetica Cannabinoidea (K2 50) | JWH-018 acidum 5-pentanoicum/JWH-073 4-acidi butanoicum | 50 |
| Synthetica Cannabinoidea (K2 200) | JWH-018 acidum 5-pentanoicum/JWH-073 4-acidi butanoicum | 200 |
| Methamphetamine (mAMP1000/ MET1000) | D-Methamphetamine | 1,000 |
| Methamphetamine (mAMP500/ MET500) | D-Methamphetamine | 500 |
| Methamphetamine (mAMP300/ MET300) | D-Methamphetamine | 300 |
| Methylenedioxymethamphetamine (MDMA) | D,L-Methylenedioxymethamphetamine | 500 |
| Morphine (MOP300/OPI300) | Morphine | 300 |
| Methadone (MTD) | Methadone | 300 |
| Methaqualone (MQL) | Methaqualone | 300 |
| Opiates (OPI 2000) | Morphine | 2,000 |
| Oxycodone (OXY) | Oxycodone | 100 |
| Phencyclidine (PCP) | Phencyclidine | 25 |
| Propoxyphene (PPX) | Propoxyphene | 300 |
| Antidepressants tricyclic (TCA) | Nortriptyline | 1,000 |
| Marijuana (THC) | 11-nec-9-THC-9-COOH | 50 |
| Tramadol (TRA) | Tramadol | 200 |
Configurationes celeris Testi ornamenti AMRDT111 multiplex consistere potest ex aliqua compositione medicamentorum analytarum enumeratorum.
In probatione urina speciminis sursum migrat per actionem capillarem.Medicamentum, si in specimine urinae sub intentione eius abscise inest, situs ligaturae specificae anticorporis non saturabit.Anticorpus tunc agere faciet cum interdum pharmacopola conjugato et linea visibili colorata ostendet in regione probata lineae speciei pharmaci habenae.Praesentia medicamentorum supra intentionem abscissorum omnes situs ligaturae anticorporis saturabit.Ergo linea colorata non formabit in regione recta probata.
Specimen urinae medicamento-positivae non generabit lineam coloratam in regione lineae probatae speciei habenae propter medicamentorum competitions, dum speciminis urinae negativae pharmacopolam generabit lineam in regione recta probata propter absentiam pharmaci competition.
Ut pro potestate processualis servetur, linea colorata semper in regione ditionis lineae apparebit, indicans volumen proprium speciminis additum esse et membranam wicking incidisse.
